Betta Pharmaceuticals Hits Day High with Strong 8.24% Intraday Surge

Betta Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.24% on May 29, 2026. The stock reached an intraday high of CNY 53.55, marking a notable achievement for the company within the pharmaceuticals and biotechnology sector. In comparison to the broader market, Betta's one-day performance stands out against the China Shanghai Composite, which declined by 0.73%. Over the past week, Betta has shown resilience with an increase of 8.26%, while the composite index fell by 1.08%. The company's one-month performance also reflects a positive trend, with a gain of 9.36% compared to the composite's slight decline of 0.95%. Despite these recent gains, Betta Pharmaceuticals has faced challenges over the longer term, with a one-year performance showing a decline of 5.83%, contrasting sharply with the composite's impressive 20.96% return. The company's market capitalization stands at CNY 20,911 million, and it maintains a price-to-earnings ratio of 46.00, indicating a premium valuation in the current market landscape.